Blog8 March 2022 The future of rare disease research Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may... Learn more
White papers & guides8 March 2022 What patient experience can learn from the 7 Principles of Universal Design | White paper Castor explores how clinical researchers improve the participant experience by having good user design in their patient-facing technology Learn more
White papers & guides29 November 2021 Getting Started with DCT in 2022 Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these... Learn more
Webinar It’s a Matter of Choice: Hybrid eConsent for On-Site or Remote Patient Enrollment Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy... Learn more
White papers & guides29 September 2021 eBook: eConsent Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key... Learn more
Blog28 September 2021 3 Ways eConsent Tackles the Challenges of Modern Clinical Trials Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it's now a major part of clinical research.... Learn more
News20 September 2021 Trialbee and Castor Partner to Democratize Access and Simplify Enrollment to Clinical Trials Globally Trialbee, the leading enrollment performance company, and Castor, a leading provider of decentralized and hybrid clinical trial solutions,... Learn more
Blog1 September 2021 The evolution of eConsent Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very... Learn more
Blog23 August 2021 What Is eConsent in Clinical Trials? eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future... Learn more
News18 August 2021 Castor Leads Next-Gen Clinical Trials that Support Digital Therapeutics Castor is supporting the next generation of digital therapeutics that can improve patient lives with disease-modifying potential. Learn more
Blog5 August 2021 Three Ways Remote eConsent Improves Trial Efficiency eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for... Learn more
White papers & guides29 July 2021 eConsent Readiness in 12 Countries eConsent is imperative for continuing research during the COVID-19 pandemic and beyond, but regulations can vary widely across... Learn more
News28 July 2021 Castor Launches Scalable Patient Enrollment and eConsent Platform to Increase Patient Access and Reduce Recruitment Timelines Castor's new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations... Learn more
Blog26 July 2021 Video Conferencing for Remote eConsent: 5 Reasons to Make the Switch Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5... Learn more
Blog16 July 2021 How to Prepare an IRB Submission for a Remote eConsent Study If you are planning on using eConsent in a trial, you’ll need to include it in your IRB... Learn more
Blog13 July 2021 Understanding the Nuances of Informed Consent in Clinical Trials Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there... Learn more
Blog1 July 2021 The True Meaning & Value of eConsent in Clinical Trials The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the... Learn more
Blog10 March 2021 Castor Inks Big Pharma Deal As Decentralized Trials Business Continues to Show Exponential Growth Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing... Learn more
